SOPHROSYNE PHARMACEUTICALS
Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Apr 2024)
What this means for you
This application is over — abandoned 15 Apr 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88813781
- Mark type
- Stylized text
- Filed
- 27 Feb 2020
- Published for opposition
- 12 Jan 2021
- Abandoned
- 15 Apr 2024
- Attorney of record
- Aric S. Jacover
Goods and services
- Class 042 — Scientific and technological services: Research and development for FDA-approved prescription medications to address alcohol use disorder (AUD) and other addiction disorders, excluding nutritional supplements
Owner
- Sophrosyne Holdings LLC, Chicago, IL, US
- Sophrosyne Holdings LLC, Chicago, IL, US
Prosecution history
- 15 Apr 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 15 Apr 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Sept 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Sept 2023 — SOU EXTENSION 5 GRANTED
- 06 Sept 2023 — SOU EXTENSION 5 FILED
- 14 Sept 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Sept 2023 — SOU TEAS EXTENSION RECEIVED
- 23 Feb 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Feb 2023 — SOU EXTENSION 4 GRANTED
- 21 Feb 2023 — SOU EXTENSION 4 FILED
- 21 Feb 2023 — SOU TEAS EXTENSION RECEIVED
- 06 Sept 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Sept 2022 — SOU EXTENSION 3 GRANTED
- 02 Sept 2022 — SOU EXTENSION 3 FILED
- 02 Sept 2022 — SOU TEAS EXTENSION RECEIVED